BioNTech SE / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €3.56B +16.9% -€63.96M -88.1% -1.8% +0.16 pp -€982.00M +0.3% -27.6% +0.046 pp
    (estimated) €3.05B +11.9% -€539.33M -42.5% -17.7% +0.17 pp -€978.80M -15.9% -32.1% +0.11 pp
    (estimated) €2.72B +7.3% -€938.71M -0.4% -34.5% +0.027 pp -€1.16B +14.3% -42.7% -0.026 pp
    (estimated) €2.54B +16.8% -€942.90M -15.4% -37.2% +0.14 pp -€1.02B +112.9% -40.1% -0.18 pp
    (estimated) €2.17B -21.1% -€1.11B +67.6% -51.3% -0.27 pp -€477.94M -172.4% -22.0% -0.46 pp
    €2.75B -28.0% -€665.30M -171.5% -24.2% -0.49 pp €660.00M -89.1% 24.0% -1.4 pp
    €3.82B -77.9% €930.30M -90.1% 24.4% -0.30 pp €6.08B -56.4% 159.1% +0.79 pp
    €17.31B -8.8% €9.43B -8.3% 54.5% +0.0026 pp €13.94B +1,235.7% 80.5% +0.75 pp
    €18.98B +3,834.4% €10.29B +67,613.8% 54.2% +0.51 pp €1.04B +1,350.1% 5.5% -0.094 pp
    €482.33M +344.2% €15.20M -108.5% 3.2% +1.7 pp €71.97M -156.5% 14.9% +1.3 pp
    €108.59M -14.9% -€179.17M +273.1% -165.0% -1.3 pp -€127.46M -1,417.5% -117.4% -1.2 pp
    €127.58M +107.1% -€48.02M -43.9% -37.6% +1.0 pp €9.67M +86.8% 7.6% -0.0083 pp
    €61.60M -€85.65M -139.1% €5.18M 8.4%

    Notifications